D. van der Heijde

5.7k citations

36 papers · 3.2k indexed · 2 hit papers · h-index 22

Rheumatology top 0.2%
Hematology top 1%
Surgery top 5%
Immunology top 5%
Pharmacology top 2%

Co-authors: Nicholas Bellamy D Whalley M Dougados Stephen P. McKenna I. H. Nuver-Zwart Roy D. Altman F. W. J. Gribnau Z. de Jong
Topics: Rheumatoid Arthritis Research and Therapies (22 papers)Spondyloarthritis Studies and Treatments (8 papers)Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers)
Cited by: Rheumatology Hematology Immunology
Journals: The Lancet Annals of the Rheumatic Diseases Osteoarthritis and Cartilage
Partner nations: Netherlands United States Australia

In The Last Decade

D. van der Heijde

34 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

2004 662 citations Pham Hai Thanh, D. van der Heijde et al. Osteoarthritis and Cartilage profile →
EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS

1989 457 citations D. van der Heijde, F. W. J. Gribnau et al. The Lancet profile →

Peers

Countries citing papers authored by D. van der Heijde

Since Specialization

Citations

This map shows the geographic impact of D. van der Heijde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van der Heijde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van der Heijde more than expected).

Fields of papers citing papers by D. van der Heijde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. van der Heijde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van der Heijde. The network helps show where D. van der Heijde may publish in the future.

Co-authorship network of co-authors of D. van der Heijde

This figure shows the co-authorship network connecting the top 25 collaborators of D. van der Heijde. A scholar is included among the top collaborators of D. van der Heijde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. van der Heijde. D. van der Heijde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	POS0182 MINIMAL CLINICALLY IMPORTANT IMPROVEMENT (MCII) AND PATIENT ACCEPTABLE SYMPTOM STATE (PASS) FOR PAIN AND FUNCTION INSTRUMENTS IN HAND OSTEOARTHRITIS (OA) 2021 ·Annals of the Rheumatic Diseases ·Féline P B Kroon,(unknown),D. van der Heijde,M. Kloppenburg	1
2	Illness Perceptions and Outcomes in Patients with Inflammatory Bowel Disease: Is Coping a Mediator? 2016 ·International Journal of Behavioral Medicine ·(unknown),(unknown),Manja Vollmann,D. van der Heijde,Roeland A. Veenendaal,Herma H. Fidder,Daniël W. Hommes,Ad A. Kaptein,Andrea E. van der Meulen‐de Jong,Margreet Scharloo	37
3	Construct validity of the Doyle Index in the outcome domain of joint activity in hand osteoarthritis patients 2016 ·Osteoarthritis and Cartilage ·(unknown),(unknown),Marion C Kortekaas,F.R. Rosendaal,D. van der Heijde,M. Kloppenburg	2
4	Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis 2016 ·Arthritis Care & Research ·Martín Rudwaleit,James T. Rosenbaum,Robert Landewé,Helena Marzo‐Ortega,Joachim Sieper,D. van der Heijde,O. Davies,Holger Bartz,Bengt Hoepken,T. Nurminen,Atul Deodhar	65
5	IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities 2014 ·Lara D. Veeken ·Diahann T. S. L. Jansen,Marjolijn Hameetman,Jeroen van Bergen,T. Huizinga,D. van der Heijde,René E. M. Toes,F. van Gaalen	45
6	Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited 2013 ·Annals of the Rheumatic Diseases ·Victoria Navarro‐Compán,D. van der Heijde,(unknown),Colin G. Miller,Ron Wolterbeek,Robert Landewé	14
7	Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials 2013 ·Lara D. Veeken ·Victoria Navarro‐Compán,R. B. M. Landewé,(unknown),Colin G. Miller,Dong Xu,Ron Wolterbeek,D. van der Heijde	2
8	Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial 2012 ·Lara D. Veeken ·Edward Keystone,Bernard Combe,Josef S Smolen,Vibeke Strand,Niti Goel,Ronald van Vollenhoven,Philip J. Mease,Robert Landewé,Roy Fleischmann,K. Luijtens,D. van der Heijde	34
9	The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy 2007 ·Annals of the Rheumatic Diseases ·D. van der Heijde,(unknown),(unknown),Cătălin Codreanu,E. Martín Mola,Ron Pedersen,B Freundlich,(unknown)	28
10	The Addition of Etanercept to Methotrexate and Methotrexate to Etanercept Monotherapies Improves Clinical Efficacy in Ra Patients Despite Low-Moderate Disease Activity at Baseline: Results of the TEMPO Extension Trial (Year 4) 2006 ·JCR Journal of Clinical Rheumatology ·D. van der Heijde,E. Martín Mola,Reijo Luukkainen,(unknown),Saeed Fatenejad,(unknown),(unknown),B Freundlich,David J. Chang	1
11	Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial 2005 ·Annals of the Rheumatic Diseases ·D. van der Heijde,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	76
12	The Role of a Computerised Case-based Testing Procedure in Practice Performance Assessment 2005 ·Advances in Health Sciences Education ·Lambert Schuwirth,Simone Gorter,D. van der Heijde,Jan‐Joost Rethans,(unknown),H. Houben,S van der Linden,Cees van der Vleuten,Albert J.J.A. Scherpbier	14
13	OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.breakdown → 2004 ·Osteoarthritis and Cartilage ·Pham Hai Thanh,D. van der Heijde,Roy D. Altman,Jennifer J. Anderson,Nicholas Bellamy,Marc C. Hochberg,Lee S. Simon,Vibeke Strand,T. Woodworth,M Dougados	662
14	Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis 2002 ·Annals of the Rheumatic Diseases ·Lynda Doward,Anneke Spoorenberg,Stuart A. Cook,D Whalley,Philip Helliwell,Lesley Kay,Stephen P. McKenna,Alan Tennant,D. van der Heijde,M A Chamberlain	457
15	Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment? 2001 ·Annals of the Rheumatic Diseases ·D. van der Heijde	52
16	A report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative 2000 ·Osteoarthritis and Cartilage ·Maxime Dougados,(unknown),D. van der Heijde,D A Bloch,Nicholas Bellamy,Roy D. Altman	146
17	Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis 1999 ·Lara D. Veeken ·D. van der Heijde,(unknown),F. H. M. Nieman,R. Rau,Maarten Boers	160
18	The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument 1997 ·Lara D. Veeken ·Z. de Jong,D. van der Heijde,Stephen P. McKenna,D Whalley	192
19	Quality of life in rheumatoid arthritis 1997 ·Lara D. Veeken ·D Whalley,S. P. McKenna,Z. de Jong,D. van der Heijde	166
20	EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITISbreakdown → 1989 ·The Lancet ·D. van der Heijde,(unknown),F. W. J. Gribnau,I. H. Nuver-Zwart,(unknown)	457

About D. van der Heijde

D. van der Heijde is a scholar working on Rheumatology, Pathology and Forensic Medicine and Psychiatry and Mental health, having authored 36 papers that have together received 3.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (22 papers), Spondyloarthritis Studies and Treatments (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). The work is most often cited by research in Rheumatology (2.7k citations), Hematology (828 citations) and Immunology (555 citations). D. van der Heijde has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Nicholas Bellamy, D Whalley, M Dougados, Stephen P. McKenna, I. H. Nuver-Zwart, Roy D. Altman, F. W. J. Gribnau, Z. de Jong, Vibeke Strand and Pham Hai Thanh. Their work appears in journals such as The Lancet, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact